Domains featuring this topic
Explore the domains where this topic appears.
Neurodegeneration: From Mechanisms to Precision Diagnosis and Therapies
This Keystone Symposium integrates fundamental mechanisms, precision diagnostics, and therapeutic development for Alzheimer's disease, non-Alzheimer dementias, and other neurodegenerative disorders. Joint programming with the Neural-Immune Interactions meeting connects disease mechanisms and clinical strategy with immune modulation of central nervous system biology.
“A Focus on 3D Printed Lenses: Rapid prototyping, low-cost microscopy and enhanced imaging for the life sciences”
High-quality glass lenses are commonplace in the design of optical instrumentation used across the biosciences. However, research-grade glass lenses are often costly, delicate and, depending on the prescription, can involve intricate and lengthy manufacturing - even more so in bioimaging applications. This seminar will outline 3D printing as a viable low-cost alternative for the manufacture of high-performance optical elements, where I will also discuss the creation of the world’s first fully 3D printed microscope and other implementations of 3D printed lenses. Our 3D printed lenses were generated using consumer-grade 3D printers and pose a 225x materials cost-saving compared to glass optics. Moreover, they can be produced in any lab or home environment and offer great potential for education and outreach. Following performance validation, our 3D printed optics were implemented in the production of a fully 3D printed microscope and demonstrated in histological imaging applications. We also applied low-cost fabrication methods to exotic lens geometries to enhance resolution and contrast across spatial scales and reveal new biological structures. Across these applications, our findings showed that 3D printed lenses are a viable substitute for commercial glass lenses, with the advantage of being relatively low-cost, accessible, and suitable for use in optical instruments. Combining 3D printed lenses with open-source 3D printed microscope chassis designs opens the doors for low-cost applications for rapid prototyping, low-resource field diagnostics, and the creation of cheap educational tools.
PhenoSign - Molecular Dynamic Insights
Do You Know Your Blood Glucose Level? You Probably Should! A single measurement is not enough to truly understand your metabolic health. Blood glucose levels fluctuate dynamically, and meaningful insights require continuous monitoring over time. But glucose is just one example. Many other molecular concentrations in the body are not static. Their variations are influenced by individual physiology and overall health. PhenoSign, a Swiss MedTech startup, is on a mission to become the leader in real-time molecular analysis of complex fluids, supporting clinical decision-making and life sciences applications. By providing real-time, in-situ molecular insights, we aim to advance medicine and transform life sciences research. This talk will provide an overview of PhenoSign’s journey since its inception in 2022—our achievements, challenges, and the strategic roadmap we are executing to shape the future of real-time molecular diagnostics.
Virtual Brain Twins for Brain Medicine and Epilepsy
Over the past decade we have demonstrated that the fusion of subject-specific structural information of the human brain with mathematical dynamic models allows building biologically realistic brain network models, which have a predictive value, beyond the explanatory power of each approach independently. The network nodes hold neural population models, which are derived using mean field techniques from statistical physics expressing ensemble activity via collective variables. Our hybrid approach fuses data-driven with forward-modeling-based techniques and has been successfully applied to explain healthy brain function and clinical translation including aging, stroke and epilepsy. Here we illustrate the workflow along the example of epilepsy: we reconstruct personalized connectivity matrices of human epileptic patients using Diffusion Tensor weighted Imaging (DTI). Subsets of brain regions generating seizures in patients with refractory partial epilepsy are referred to as the epileptogenic zone (EZ). During a seizure, paroxysmal activity is not restricted to the EZ, but may recruit other healthy brain regions and propagate activity through large brain networks. The identification of the EZ is crucial for the success of neurosurgery and presents one of the historically difficult questions in clinical neuroscience. The application of latest techniques in Bayesian inference and model inversion, in particular Hamiltonian Monte Carlo, allows the estimation of the EZ, including estimates of confidence and diagnostics of performance of the inference. The example of epilepsy nicely underwrites the predictive value of personalized large-scale brain network models. The workflow of end-to-end modeling is an integral part of the European neuroinformatics platform EBRAINS and enables neuroscientists worldwide to build and estimate personalized virtual brains.